Institutional investors purchased a net $3.7 million shares of GSK during the quarter ended December 2013 and now own 11.18% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MERRILL LYNCH, PIERCE, FENNER & ... Bought 4.8 Million shares of GlaxoSmithKline PLC
RENAISSANCE TECHNOLOGIES LLC Bought 2.5 Million shares of GlaxoSmithKline PLC
WESTWOOD MANAGEMENT CORP. (TEXAS... Bought 2.1 Million shares of GlaxoSmithKline PLC